HIGHLIGHTED ARTICLES FROM ANNALS OF SURGICAL ONCOLOGY
Weekly Update
Predictors of Early Versus Late Recurrence in Invasive Lobular Carcinoma of the Breast: Impact of Local and Systemic Therapy
September 21, 2023
Citation: Rothschild, H.T., Clelland, E.N., Mujir, F. et al. Predictors of Early Versus Late Recurrence in Invasive Lobular Carcinoma of the Breast: Impact of Local and Systemic Therapy. Ann Surg Oncol 30, 5999–6006 (2023). https://doi.org/10.1245/s10434-023-13881-x
Synopsis: Invasive carcinoma (ILC) is known for high cumulative late recurrence risk, which makes surveillance a clinical priority. In a multivariable analysis of ILC cases from an institutional database, different factors and treatment received were associated with timing of recurrence.
Impact of Indocyanine Green Fluorescence Imaging on Lymphadenectomy Quality During Laparoscopic Distal Gastrectomy for Gastric Cancer (Greeneye): An Adaptative, Phase 2, Clinical Trial
September 21, 2023
Citation: Sposito, C., Maspero, M., Conalbi, V. et al. Impact of Indocyanine Green Fluorescence Imaging on Lymphadenectomy Quality During Laparoscopic Distal Gastrectomy for Gastric Cancer (Greeneye): An Adaptative, Phase 2, Clinical Trial. Ann Surg Oncol 30, 6803–6811 (2023). https://doi.org/10.1245/s10434-023-13848-y
Synopsis: In this Simon two-stage phase II study, preoperative peritumoral ICG injection and subsequent completion lymphadenectomy improved the quality of D2 lymphadenectomy during laparoscopic distal gastrectomy.
Listen to the ASO's new podcast, Speaking of SurgOnc®
Speaking of SurgOnc® is a podcast brought to you by the Annals of Surgical Oncology (ASO) and the Society of Surgical Oncology (SSO).
The series is hosted by ASO Deputy Editor Dr. Frederick L. (Rick) Greene, who will expand upon ideas from articles published in the Annals. Once a month, Dr. Greene will interview authors and leading experts in surgical oncology.
Listen to the podcast here.
ASO is the journal of choice of surgical oncologists and cancer multidisciplinary teams worldwide regarding surgical oncology research and education, and benefits surgeons, oncologists, hematologists, radiologists, general practitioners, pathologists, researchers, academicians, and other clinical professionals interested in all aspects of the surgical treatment of cancer. ASO strives to improve the practice environment in which high-quality surgical oncology care is delivered, to enhance the quality of life and survival of the surgical patient with cancer.
Join the conversation! Follow the journal on Twitter and Instagram. Help to expand the reach of the journal to support the research and practice needs of surgical oncologists and their patients.
